Ratings by CLSA (Michael Luo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Thermo Fisher Scientific | TMO | New Coverage | Outperform (2) (N/A) |
600.50 (694.02) |
15.57% | Details | |
| 7/20/2026 | Charles River Labs | CRL | Downgrade | Hold (3) (Outperform (2)) |
229.16 (344.87) |
50.49% | Details | |
| 5/29/2026 | Charles River Labs | CRL | Upgrade | Outperform (2) (Hold (3)) |
164.49 (229.16) |
39.32% | Details | |
| 11/18/2024 | Charles River Labs | CRL | Downgrade | High-Conviction Underperform (5) (Outperform (2)) |
196.90 (164.49) |
-16.46% | Details |
